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The 1-aryl tetrahydroisoquinolines have attracted great attention in medicinal chemistry 
due to their biological activity. These compounds present antitumor, anti-HIV and 
antibacterial activities. Several analogues of 1-aryl tetrahydroisoquinoline are used for 
the treatment of neurodegenerative diseases such as Parkinson´s and Alzheimer´s 
diseases since also act as dopaminergic antagonists and N-methyl-D-aspartate 
receptor antagonist. [1]  
 
The 1-substituted tetrahydro-3-benzazepines have also been studied for their affinity to 
the Phencylclidine binding site of the NMDA receptor as well as for their affinity to the 
dopaminergic receptors. [2] 
 
In the last years, various methods have been carried out to satisfy the demand of novel 
tetrahydroisoquinolines and tetrahydro-3-benzazepines. We have synthesized nor-1-
aryl tetrahydroisoquinolines with different substituents in the aryl group of C-1 (H, 
NMe2, SMe, NO2, NH2). In addition to this, we have performed the synthesis of nor-
tetrahydro-3-benzazepinas by different routes, obtaining the best results via opening of 
epoxides by arylphenethylamines and subsequent cyclization. 
 
The nor-tetrahydroisoquinolines and nor-tetrahydro-3-benzazepines have been 
derivatized to obtain appropiate adsorbates which can be attached to nanoparticles. 
This fact is crutial in drug delivery systems as well as in the improvement of the 
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